March 30th, 2015
How Do You Like Them Apples?
Larry Husten, PHD
An apple a day does not appear to keep the doctor away but, a new study semi-seriously suggests, it may keep the pharmacist away. Although apples have long been considered a healthy snack, whether eating apples actually reduces healthcare use has not been assessed until now. In a paper published in JAMA Internal Medicine researchers examined […]
March 27th, 2015
Fighting the Contradiction: A Hospital Rolls Out the Red Carpet for Smokers
Jean-Pierre Usdin, MD
Jean-Pierre Usdin is frustrated with his “Tobacco-Free” hospital’s accommodations for smokers that encourage them to keep smoking instead of supporting them to quit.
March 23rd, 2015
Selections from Richard Lehman’s Literature Review: March 23rd
Richard Lehman, BM, BCh, MRCGP
This week’s topics include antiplatelet therapy duration following bare metal or drug-eluting coronary stents, thrombolysis in acute ischemic stroke, and more.
March 23rd, 2015
Dangerous Interaction: New Hepatitis C Drug and Old Arrhythmia Drug
Larry Husten, PHD
Late last week Gilead Sciences issued a warning about a rare but potentially fatal interaction between its stellar new hepatitis C drug sofosbuvir and amiodarone, a potent but tricky antiarrhythmic agent. Sofosbuvir is marketed as Sovaldi and, in combination with another antiviral agent, as Harvoni. Amiodarone is a class III antiarrhythmic with a number of […]
March 18th, 2015
Networking Opportunities and Cardiology Bootcamp at ACC.15
Saurav Chatterjee, MD
Saurav Chatterjee reports from the 2015 ACC conference with even more exciting opportunities for fellows in training and other health care professionals.
March 16th, 2015
Learning Opportunities for Fellows-in-Training at ACC 2015
Saurav Chatterjee, MD
Saurav Chatterjee reports on exciting opportunities for fellows in training available at the 2015 ACC conference.
March 16th, 2015
Selections from Richard Lehman’s Literature Review: March 16th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include endovascular therapy for ischemic stroke with perfusion-imaging selection, innovation and implementation in CV medicine, statin intolerance, and more.
March 15th, 2015
More Information Emerges About the PCSK9 Inhibitors
Larry Husten, PHD
New information emerged today about two new cholesterol-lowering drugs that have been attracting a lot of attention. Data about the PCSK9 inhibitors — evolocumab, under development by Amgen, and alirocumab, under development by Sanofi and Regeneron — were presented at the American College of Cardiology meeting in San Diego and published simultaneously in the New England Journal of Medicine. […]
March 14th, 2015
Has CT Angiography Lived Up to Its Early Promise?
Larry Husten, PHD
Computed tomographic angiography (CTA) enjoyed an explosion of growth over the past decade or more, fueled by enthusiasm for its ability to deliver speedy, high-resolution images of the coronary arteries. Many anticipated that CTA would prove its worth and justify its expense and radiation dose. As explained by one cardiologist, Duke University’s Dan Mark, with […]
March 14th, 2015
ACC.15 Headquarters
wpengine
As ACC.15 unfolds, check our Headquarters page for all of our latest coverage!
NEJM Journal Watch — Recent Cardiology Articles- Patients Need Standardized Education for Accurate Home Blood Pressure Monitoring
- Does P2Y12 Inhibitor Pretreatment Improve Outcomes in Non–ST-Segment Elevation Acute Coronary Syndromes?
- Is Anticoagulation Useful for Patients with Subclinical Atrial Fibrillation?
- Is Anticoagulation Alone Sufficient After Caval or Iliofemoral Venous Stenting for PTS?
- Antithrombotic Therapy for Atrial Fibrillation and ACS or PCI: Choosing a Regimen Based on the Totality of Events